Search

Quest Diagnostics Inc

Lezárt

SzektorEgészségügy

235.5 0.06

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

232

Maximum

236.07

Fő mutatók

By Trading Economics

Bevétel

70M

334M

Értékesítés

148M

3B

P/E

Szektor átlag

25.201

56.597

Egy részvényre jutó nyereség

3.12

Osztalékhozam

1.39

Profit margin

10.976

Munkavállalók

46,000

EBITDA

47M

481M

Ajánlások

By TipRanks

Ajánlások

Vétel

12 hónapos előrejelzés

+7.86% upside

Osztalékok

By Acuity

Osztalékhozam

Szektor átlag

1.39%

2.18%

Következő eredményjelentés

2026. okt. 20.

Következő osztalékfizetési dátum

2026. okt. 21.

Következő korábbi osztalék dátum

2026. okt. 6.

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

3.2B

26B

Előző nyitás

235.44

Előző zárás

235.5

Hangulat hírek alapján

By Acuity

15%

85%

12 / 339 Rangsor szerint Healthcare

Quest Diagnostics Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. szept. 9. 21:01 UTC

News

Quest Diagnostics shares are lower after announcing a new lab test panel for Apple Health app users, priced at $119.

2026. szept. 8. 23:26 UTC

Quest Diagnostics Inc shares are higher in after-market hours, reaching a peak cumulative return of 0.78%. No specific news was identified to explain this movement.

2026. szept. 4. 19:36 UTC

Quest Diagnostics shares are lower amid rising Treasury yields and expectations of tighter monetary policy from the Federal Reserve. The stock is below its 20-day moving average.

2026. szept. 3. 21:04 UTC

Quest Diagnostics Inc shares are higher in after-market trading, showing notable strength during the session. No specific news was identified to explain the movement.

2026. szept. 2. 20:03 UTC

News

Quest Diagnostics has signed a multi-year agreement with Renalytix PLC for kidney testing, contributing to shares trading higher during Wednesday's session.

2026. szept. 1. 23:36 UTC

News

Quest Diagnostics has signed a multi-year agreement with Renalytix PLC for kidneyintelX.dkd testing, contributing to a modest rise in shares during after-market hours.

2026. aug. 31. 23:26 UTC

Quest Diagnostics Inc is rising in after-market trading, rebounding from three days of declines. Broader market dynamics may be influencing investor sentiment.

2026. aug. 28. 19:46 UTC

Quest Diagnostics Inc shares are lower today, continuing a decline since Thursday. Broader market conditions and inflation concerns may be influencing the price action.

2026. aug. 27. 23:06 UTC

Quest Diagnostics shares are trading lower in after-market hours. The decline follows three consecutive sessions of gains amid mixed market sentiment.

2026. aug. 26. 19:46 UTC

Quest Diagnostics shares are lower today, reflecting broader market trends amid rising consumer prices, as indicated by the recent PCE price index data.

2026. aug. 25. 23:42 UTC

Correlated Moves

Quest Diagnostics Inc shares declined in after-market trading, following a similar trend seen in Labcorp Holdings Inc. The stock moved lower since Tuesday's close.

2026. aug. 24. 23:36 UTC

Event

Quest Diagnostics announced developments in its Alzheimer’s testing portfolio, with shares trading lower in after-market hours amid broader market volatility.

2026. aug. 21. 23:01 UTC

Quest Diagnostics shares declined in after-market trading, despite remaining above their 20-day moving average and near the upper end of their one-month range.

2026. aug. 20. 20:01 UTC

Quest Diagnostics Inc is trading higher, continuing its upward trend since Wednesday. The stock reached a session high earlier before pulling back slightly.

2026. aug. 19. 23:56 UTC

Quest Diagnostics Inc shares are higher in after-market hours, continuing a trend of four consecutive sessions finishing above their 20-day moving average.

2026. aug. 17. 19:46 UTC

Correlated Moves
News

Quest Diagnostics Inc's shares are higher, supported by Zacks Research raising Q3 EPS estimates to $2.82 from $2.79 following strong Q2 results.

2026. aug. 12. 19:46 UTC

Quest Diagnostics shares are higher, reflecting broader market gains from positive inflation sentiment. The stock remains above its 20-day moving average.

2026. aug. 11. 19:26 UTC

Quest Diagnostics shares are higher today, reflecting a general upward trend since Monday. Investors await upcoming U.S. inflation reports that may impact market sentiment.

2026. aug. 10. 23:36 UTC

Quest Diagnostics Inc shares are trading higher in after-market hours, showing notable upward movement despite no specific company news identified.

2026. aug. 7. 21:01 UTC

Quest Diagnostics Inc. shares are higher in after-market trading, reflecting strong performance above the 20-day moving average and near the one-month range's upper end.

2026. aug. 6. 23:01 UTC

Quest Diagnostics Inc. shares declined in after-market trading, reversing a three-session upward trend. The stock remains above its 20-day moving average.

2026. aug. 5. 19:36 UTC

Quest Diagnostics Inc shares are higher amid positive market sentiment and easing inflation concerns related to falling crude oil prices. The stock is near its one-month high.

2026. aug. 4. 22:02 UTC

Quest Diagnostics Inc shares declined in after-market trading, despite broader positive market sentiment. No specific news was identified to explain the drop.

2026. aug. 3. 19:46 UTC

Quest Diagnostics Inc. shares are lower today, continuing a trend of declines after four consecutive sessions of lower closes. No specific news has been identified.

2026. júl. 31. 20:04 UTC

Correlated Moves

Quest Diagnostics is lower today, reflecting broader declines in the Health Care Services sector, including a drop in Labcorp Holdings.

2026. júl. 30. 23:02 UTC

Quest Diagnostics shares are higher in after-market trading, recovering from an earlier dip. The price remains above its 20-day moving average.

2026. júl. 29. 20:08 UTC

Correlated Moves

Quest Diagnostics shares are lower amid a broader decline in the Health Care Services sub-sector, reflecting a negative trend seen since Tuesday's close.

2026. júl. 28. 23:01 UTC

Quest Diagnostics Inc shares are higher in after-market trading, maintaining upward momentum amid broader market strength and trading above their 20-day moving average.

2026. júl. 27. 17:26 UTC

News

Quest Diagnostics Inc. shares are higher today, supported by a 10% revenue increase to $3 billion for Q2 and an improved full-year outlook.

2026. júl. 24. 21:21 UTC

Quest Diagnostics Inc shares are higher in after-market hours, continuing a trend of gains over the past three sessions. No specific news was identified.

Társak összehasonlítása

Árváltozás

Quest Diagnostics Inc Előrejelzés

Célár

By TipRanks

7.86% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 254 USD  7.86%

Magas 265 USD

Alacsony 245 USD

11 Wall Street elemző 12 hónapos célárain alapulva a(z)Quest Diagnostics Inc termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Vétel

11 ratings

7

Vétel

4

Tartás

0

Eladás

Hangulat

By Acuity

12 / 339 Rangsor szerint Egészségügy

Hangulat hírek alapján

Nagyon erős bullish bizonyíték

Volatilitás

Átlag alatti

Hírmennyiség (RCV)

Átlag alatti

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk Quest Diagnostics Inc

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
help-icon Live chat